The American Cancer Society invests hundreds of millions of dollars every year to fight cancer on a global scale and has earned the public trust by demonstrating a history of careful and proven financial stewardship for over a century. We raise nearly all of our money through private individual donations, which helps to ensure our independence. We encourage people to look at how effectively we deliver on our mission, in addition to how efficiently we operate. We are deeply committed to reporting to our “shareholders” – the millions of people who support us each year.
American Cancer Society is committed to efficiency and transparency and relies on direct mail (both postal and online) and special events including Relay For Life, Making Strides Against Breast Cancer, DetermiNation, Coaches Vs. Cancer, and CEOs Against Cancer to maintain our strong volunteer and donor base as well as educate and inform the public regarding cancer prevention, early detection, and patient programs offered and available to them. We also use these events to drive a call to action for cancer prevention and screenings as well as public policy advocacy. This education and information delivery is inherent in our mission statement – to improve the lives of people with cancer and their families through advocacy, research, and patient support, to ensure everyone has an opportunity to prevent, detect, treat, and survive cancer.
We communicate and educate by postal mail, digitally, telephone, and in person at our events not only to generate income but to fulfill our mission. As a result, in accordance with the Financial Accounting Standards Board (FASB) guideline and Internal Revenue Service (IRS) guidelines, we allocate a portion of our direct mail and special event costs to program services.
As a nonprofit organization that is exempt from federal taxation, we ensure donors’ money is spent as efficiently and effectively as possible. For more information regarding these cost allocations, we invite you to view our audited financial statements where we disclose additional information in accordance with FASB. Additionally, please see Schedule G of our Form 990 for more information regarding Relay For Life and Making Strides Against Breast Cancer.
Focusing on our vision to end cancer as we know it, for everyone, the American Cancer Society Annual Report outlines our path forward, as we work to improve the lives of people with cancer and their families. The report showcases our major accomplishments, including how we touch millions of lives through continued efforts in our three mission pillars: discovery, advocacy, and patient support. Financial statements detail revenue and expenses for the calendar year, with 80% of our revenue invested in delivering our mission.
The American Cancer Society is proud to hold a four-star rating from Charity Navigator, the Better Business Bureau’s Wise Giving Alliance National Charity Seal, and the Platinum Seal of Transparency from Candid, all widely recognized and respected charity rating and watchdog groups, demonstrating our continuing commitment to accountability, transparency, and ethical practices.
The Financial Statements of the American Cancer Society, Inc., Cancer Action
and ACS Puerto Rico provide the most meaningful financial information on the entire American Cancer Society
since they are presented in accordance with generally accepted accounting principles and combine all parts of the organization in one statement.
The Board of Directors is composed of 5 officers and 16 directors. Directors are elected for a two-year term. The Board is responsible for setting policy, establishing long-term goals, monitoring general operations, and approving the organizational outcomes and allocation of resources.
The American Cancer Society, Inc. takes its mission to improve lives seriously and therefore works to protect the resources entrusted to it by the public. The Society is governed by a single Board of Directors, which is made up of volunteers from the medical and lay communities. Our system of organizational governance ensures the input of appropriate experts on decision making and strategic oversight of comprehensive nationwide operations.
The machine-readable files are made available in response to the federal Transparency in Coverage Rule and include negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine-readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.
BrightEdge is the American Cancer Society's donor-funded impact investment arm that invests in for-profit companies developing therapeutics, diagnostics, medical devices, and technologies to eradicate cancer. It invests alongside top-tier life sciences and healthcare investors with a goal of generating financial returns and patient impact. The BrightEdge Annual Report outlines how its investments will improve the lives of more than 1.5 million patients and their families.